The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global ambulance services market reached a value of US$ 45.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 76.9 Billion by 2027, exhibiting a CAGR of 9.11% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Ambulance, or paramedic, services refer to the emergency medical facilities used to transport patients that require immediate attention due to an illness or accidental injury. The ambulance services are ported to the site using specialized vehicles on the ground, air and water. These services are connected and integrated with communication and transportation networks, hospitals, trauma centers, specialty care centers and rehabilitation facilities to provide optimal care to the patients. They are used for both emergency and non-emergency situations and are integrated with tools for Basic Life Support (BLS) and Advanced Life Support (ALS) for the patients.
Significant growth in the healthcare industry across the globe is one of the key factors creating a positive outlook for the market. Furthermore, the increasing incidents of road accidents, natural calamities and medical ailments that require immediate medical attention are providing a thrust to the market growth. As the geriatric population continues to rise, the need for ambulance services is also increasing considerably for both unscheduled and irregular non-emergency and emergency situations. Moreover, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for ambulance services in the healthcare centers. Additionally, the advent of multi-specialty ambulances that are equipped with innovative tools and equipment to provide prompt and high-quality care to the patients is acting as another major growth-inducing factor. Various healthcare centers are also adopting air ambulances to transport patients with infectious diseases and critical conditions with enhanced convenience, flexibility and safety for the patient. Other factors, including the implementation of favorable government policies to promote public health, along with extensive improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global ambulance services market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on transport vehicle, emergency services and equipment.
Breakup by Transport Vehicle:
Breakup by Emergency Services:
Breakup by Equipment:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Acadian Ambulance Service Inc., Air Methods Corporation, America Ambulance Services Inc., Babcock International Group PLC, BVG India Limited, Dutch Health B.V., Falck A/S, Global Medical Response Inc., London Ambulance Service NHS Trust, Medivic Pharmaceutical PVT LTD and Ziqitza Healthcare Limited.
|Base Year of the Analysis||2021|
|Segment Coverage||Transport Vehicle, Emergency Services, Equipment, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Acadian Ambulance Service Inc., Air Methods Corporation, America Ambulance Services Inc., Babcock International Group PLC, BVG India Limited, Dutch Health B.V., Falck A/S, Global Medical Response Inc., London Ambulance Service NHS Trust, Medivic Pharmaceutical PVT LTD and Ziqitza Healthcare Limited|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Swine Healthcare Market by Product (Diagnostic Tests, Therapeutics), Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Others), Route of Administration (Injectable, Oral), Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Online Pharmacy), and Region 2023-2028
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Others), and Region 2023-2028
Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Gastric Cancer Drugs Market by Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Route of Administration (Oral, Parenteral), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at